About the Authors
- Refik Pul
-
Contributed equally to this work with: Refik Pul, Franco Morbiducci
Affiliation Department of Neurology, Hannover Medical School, Hannover, Germany
- Franco Morbiducci
-
Contributed equally to this work with: Refik Pul, Franco Morbiducci
Affiliation Department of Neurology, Hannover Medical School, Hannover, Germany
- Jelena Škuljec
-
Affiliation Department of Neurology, Hannover Medical School, Hannover, Germany
- Thomas Skripuletz
-
Affiliation Department of Neurology, Hannover Medical School, Hannover, Germany
- Vikramjeet Singh
-
Affiliations Department of Neurology, Hannover Medical School, Hannover, Germany, Center for Systems Neuroscience, Hannover, Germany
- Ute Diederichs
-
Affiliation Department of Neurology, Hannover Medical School, Hannover, Germany
- Niklas Garde
-
Affiliation Department of Neurology, Hannover Medical School, Hannover, Germany
- Elke Verena Voss
-
Affiliation Department of Neurology, Hannover Medical School, Hannover, Germany
- Corinna Trebst
-
Affiliation Department of Neurology, Hannover Medical School, Hannover, Germany
- Martin Stangel
-
* E-mail: Stangel.Martin@MH-Hannover.de
Affiliations Department of Neurology, Hannover Medical School, Hannover, Germany, Center for Systems Neuroscience, Hannover, Germany
Competing Interests
RP declares that he has received travel funds from Baxter, Bayer HealthCare, Biogen, Novartis, Sanofi-Aventis, and Merck Serono in the last six years. TS declares that he has received travel funds from Novartis, Merck, and Bayer Healthcare. NG, FM and JS declare that they have no competing interests. CT has received honoraria for consultation and expert testimony as well as travel grants from Bayer Health Care, Biogen Idec, Diamed Medizintechnik GmbH, Fresenius Medical Care, Merck Serono, Novartis, Sanofi-Avnetis, Talecris Biotherapeutics GmbH, and Teva Pharmaceutical Industries. MS has received honoraria for scientific lectures and/or travel funds from Baxter, Bayer Healthcare, Biogen Idec, CSL Behring, Merck-Serono, Novartis, Sanofi-Aventis, Talecris, and Teva. EVV declares that she received travel funds from Novartis and speakers honoraria from Biogen idec in the last six years. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RP MS. Performed the experiments: RP FM JS UD VS NG EVV. Analyzed the data: RP FM JS TS NG EVV CT MS. Contributed reagents/materials/analysis tools: RP MS. Wrote the paper: RP FM TS CT MS.